Alignment Healthcare, Inc. (ALHC)
ALHC Stock Price Chart
Explore Alignment Healthcare, Inc. interactive price chart. Choose custom timeframes to analyze ALHC price movements and trends.
ALHC Company Profile
Discover essential business fundamentals and corporate details for Alignment Healthcare, Inc. (ALHC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Plans
IPO Date
26 Mar 2021
Employees
1.68k
CEO
John E. Kao
Description
Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.
ALHC Financial Timeline
Browse a chronological timeline of Alignment Healthcare, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Jul 2026
EPS estimate is $0.13, while revenue estimate is $1.31bn.
Earnings released on 30 Apr 2026
EPS came in at $0.05 surpassing the estimated $0.01 by +400.00%, while revenue for the quarter reached $1.24bn , beating expectations by +1.42%.
Earnings released on 26 Feb 2026
EPS came in at -$0.05 surpassing the estimated -$0.15 by +66.67%, while revenue for the quarter reached $1.01bn , beating expectations by +0.93%.
Earnings released on 30 Oct 2025
EPS came in at $0.02 surpassing the estimated -$0.01 by +300.00%, while revenue for the quarter reached $993.70m , beating expectations by +1.30%.
Earnings released on 30 Jul 2025
EPS came in at $0.07 surpassing the estimated -$0.07 by +200.00%, while revenue for the quarter reached $1.02bn , beating expectations by +5.76%.
Earnings released on 1 May 2025
EPS came in at -$0.05 surpassing the estimated -$0.12 by +58.33%, while revenue for the quarter reached $926.93m , beating expectations by +4.35%.
Earnings released on 27 Feb 2025
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%, while revenue for the quarter reached $701.24m , beating expectations by +3.52%.
Earnings released on 29 Oct 2024
EPS came in at -$0.14 matching the estimated -$0.14, while revenue for the quarter reached $692.43m , beating expectations by +2.51%.
Earnings released on 1 Aug 2024
EPS came in at -$0.13 surpassing the estimated -$0.14 by +7.14%, while revenue for the quarter reached $681.29m , beating expectations by +6.84%.
Earnings released on 2 May 2024
EPS came in at -$0.25 falling short of the estimated -$0.24 by -4.17%, while revenue for the quarter reached $628.60m , beating expectations by +5.21%.
Earnings released on 27 Feb 2024
EPS came in at -$0.25 falling short of the estimated -$0.22 by -13.64%, while revenue for the quarter reached $465.39m , beating expectations by +4.68%.
Earnings released on 2 Nov 2023
EPS came in at -$0.19 matching the estimated -$0.19, while revenue for the quarter reached $456.71m , beating expectations by +3.44%.
Earnings released on 3 Aug 2023
EPS came in at -$0.15 surpassing the estimated -$0.21 by +28.57%, while revenue for the quarter reached $462.38m , beating expectations by +5.32%.
Earnings released on 4 May 2023
EPS came in at -$0.20 surpassing the estimated -$0.25 by +20.00%, while revenue for the quarter reached $439.16m , beating expectations by +1.80%.
Earnings released on 28 Feb 2023
EPS came in at -$0.31 falling short of the estimated -$0.30 by -3.33%, while revenue for the quarter reached $361.81m , beating expectations by +6.07%.
Earnings released on 3 Nov 2022
EPS came in at -$0.22 surpassing the estimated -$0.25 by +12.00%, while revenue for the quarter reached $360.35m , beating expectations by +8.08%.
Earnings released on 4 Aug 2022
EPS came in at -$0.06 surpassing the estimated -$0.26 by +76.92%, while revenue for the quarter reached $366.47m , beating expectations by +8.75%.
Earnings released on 5 May 2022
EPS came in at -$0.23 surpassing the estimated -$0.24 by +4.17%, while revenue for the quarter reached $345.53m , beating expectations by +3.92%.
Earnings released on 3 Mar 2022
EPS came in at -$0.27 surpassing the estimated -$0.28 by +3.57%, while revenue for the quarter reached $298.27m , beating expectations by +10.65%.
Earnings released on 4 Nov 2021
EPS came in at -$0.26 falling short of the estimated -$0.17 by -52.94%, while revenue for the quarter reached $293.47m , beating expectations by +6.09%.
Earnings released on 9 Aug 2021
EPS came in at -$0.25 falling short of the estimated -$0.11 by -127.27%, while revenue for the quarter reached $308.95m , beating expectations by +48.15%.
ALHC Stock Performance
Access detailed ALHC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
